AxiosDeep Dive: The drug pricing mazeAxios - Bob HermanThe system for setting drug prices in the U.S. is a labyrinth. It can be enormously frustrating for patients — and enormously rewarding for the drug …
AxiosExclusive poll: Americans don't think Trump will reduce drug pricesAxios - Sam BakerAmericans don’t have much confidence in President Trump’s pledge to bring down drug prices, according to our latest Axios/SurveyMonkey poll. Why it …
AxiosWhy drug prices matter: Lives and livelihoods are at stakeAxios - Sam BakerDrug prices are a big deal politically because they’re a big deal personally. Time after time, the issue is thrust back into the spotlight by virtue …
AxiosWhat Washington is likely to do about drug pricesAxios - Sam BakerPharma was happy when President Trump first released his blueprint to lower drug prices, which mainly targeted industry middlemen, not drugmakers, …
AxiosThe drug price middlemenAxios - Bob HermanWe keep mentioning “middlemen” as part of the complex, expensive drug supply chain. They’re actually called pharmacy benefit managers, or PBMs, and …
AxiosDefining a drug's valueAxios - Bob HermanOver the past few years, there’s been a growing push from researchers to figure out which drugs are worth their price tags. Other countries, like the …
AxiosWe're not spending as much on drugs as you thinkAxios - Sam BakerPrescription drugs are the political center of the health care debate, but we actually spend a lot more on hospital care and doctors’ visits. By the …
